Skip to main content Back to Top

Treatment of vaccine-preventable diseases – Rabies (CE)

Broadcast Date: June 17, 2023


Subscribe on iTune PodcastsListen on Google PlaySubscribe to Stitcher Podcasts Listen on Spotify Subscribe to TuneIn PodcastsSubscribe to iHeartRadio

Rabies is a rare and fatal condition that is not commonly seen in developed countries, though numerous cases are reported annually. In this episode, we will discuss a patient case and evaluate the pathophysiology, clinical presentation, and disease management of rabies.


Norm FennNorm Fenn, PharmD, BCPS, BCPPS is a Clinical Assistant Professor at Manchester University College of Pharmacy & Health Sciences and a Pediatric Clinical Pharmacist at Parkview Women's and Children's Hospital. He graduated with Honors from the University of Colorado Skaggs School of Pharmacy & Pharmaceutical Sciences. He completed his PGY-1 residency at Children’s National Medical Center and a two-year Academia & Ambulatory Care Fellowship at the Purdue University College of Pharmacy.

Michael KallenbergerMichael Kallenberger, PharmD, BCPS, DPLA graduated from University of Missouri – Kansas City in 2008 and completed his PGY1 residency at Truman Medical Centers- Kansas City in 2009. Upon residency graduation, he started the antimicrobial stewardship program at Truman Medical Centers and continued as the antimicrobial stewardship pharmacist until 2015. Michael then came to North Kansas City Hospital in 2015 to be a clinical pharmacist and took over the PGY1 residency program director role in 2021.

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.